Robert Ticktin
Geschäftsführer bei PMV PHARMACEUTICALS, INC.
Aktive Positionen von Robert Ticktin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PMV PHARMACEUTICALS, INC. | Geschäftsführer | - | - |
General Counsel | - | - |
Karriereverlauf von Robert Ticktin
Ehemalige bekannte Positionen von Robert Ticktin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TESARO INC | Corporate Officer/Principal | - | - |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology EPIRUS Biopharmaceuticals, Inc. develops monoclonal antibodies. It offers pharmaceutical products. The company is headquartered in Boston, MA. | General Counsel | 01.04.2014 | - |
EPIRUS BIOPHARMACEUTICALS, INC. | General Counsel | - | - |
Unternehmenssekretär | - | - | |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | General Counsel | - | - |
Ausbildung von Robert Ticktin
The Ohio State University | Undergraduate Degree |
Fordham University School of Law | Graduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
General Counsel | 4 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
EPIRUS BIOPHARMACEUTICALS, INC. | Health Technology |
PMV PHARMACEUTICALS, INC. | Commercial Services |
Private Unternehmen | 3 |
---|---|
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | Health Technology |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology EPIRUS Biopharmaceuticals, Inc. develops monoclonal antibodies. It offers pharmaceutical products. The company is headquartered in Boston, MA. | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Robert Ticktin
- Erfahrung